41 found
Order:
  1.  12
    Ethically Allocating COVID-19 Drugs Via Pre-Approval Access and Emergency Use Authorization.Jamie Webb, Lesha D. Shah & Holly Fernandez Lynch - 2020 - American Journal of Bioethics 20 (9):4-17.
    Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Authorization raises unique challenges at the intersection of clinical care and research....
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   14 citations  
  2.  48
    Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations.Luke Gelinas, Robin Pierce, Sabune Winkler, I. Glenn Cohen, Holly Fernandez Lynch & Barbara E. Bierer - 2017 - American Journal of Bioethics 17 (3):3-14.
    The use of social media as a recruitment tool for research with humans is increasing, and likely to continue to grow. Despite this, to date there has been no specific regulatory guidance and there has been little in the bioethics literature to guide investigators and institutional review boards faced with navigating the ethical issues such use raises. We begin to fill this gap by first defending a nonexceptionalist methodology for assessing social media recruitment; second, examining respect for privacy and investigator (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   21 citations  
  3.  5
    Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?Holly Fernandez Lynch, Arthur Caplan, Patricia Furlong & Alison Bateman-House - 2021 - American Journal of Bioethics 21 (12):4-19.
    After witnessing extraordinary scientific and regulatory efforts to speed development of and access to new COVID-19 interventions, patients facing other serious diseases have begun to ask “where’s...
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  4.  6
    Promoting Ethical Payment in Human Infection Challenge Studies.Holly Fernandez Lynch, Thomas C. Darton, Jae Levy, Frank McCormick, Ubaka Ogbogu, Ruth O. Payne, Alvin E. Roth, Akilah Jefferson Shah, Thomas Smiley & Emily A. Largent - 2021 - American Journal of Bioethics 21 (3):11-31.
    To prepare for potential human infection challenge studies involving SARS-CoV-2, we convened a multidisciplinary working group to address ethical questions regarding whether and how much SAR...
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   13 citations  
  5.  11
    When Clinical Trials Compete: Prioritising Study Recruitment.Luke Gelinas, Holly Fernandez Lynch, Barbara E. Bierer & I. Glenn Cohen - 2017 - Journal of Medical Ethics 43 (12):803-809.
    It is not uncommon for multiple clinical trials at the same institution to recruit concurrently from the same patient population. When the relevant pool of patients is limited, as it often is, trials essentially compete for participants. There is evidence that such a competition is a predictor of low study accrual, with increased competition tied to increased recruitment shortfalls. But there is no consensus on what steps, if any, institutions should take to approach this issue. In this article, we argue (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   12 citations  
  6.  6
    Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways.Holly Fernandez Lynch & Alison Bateman-House - 2020 - Journal of Law, Medicine and Ethics 48 (2):365-372.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  7.  18
    Differential Payments to Research Participants in the Same Study: An Ethical Analysis.Govind Persad, Holly Fernandez Lynch & Emily Largent - 2019 - Journal of Medical Ethics 1:10.1136/medethics-2018-105140.
    Recognizing that offers of payment to research participants can serve various purposes—reimbursement, compensation, and incentive—helps uncover differences between participants that can justify differential payment of participants within the same study. Participants with different study-related expenses will need different amounts of reimbursement to be restored to their pre-participation financial baseline. Differential compensation can be acceptable when some research participants commit more time or assume greater burdens than others, or if inter-site differences affect the value of compensation. Finally, it may be permissible (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  8.  8
    Implementing Regulatory Broad Consent Under the Revised Common Rule: Clarifying Key Points and the Need for Evidence.Holly Fernandez Lynch, Leslie E. Wolf & Mark Barnes - 2019 - Journal of Law, Medicine and Ethics 47 (2):213-231.
    The revised Common Rule includes a new option for the conduct of secondary research with identifiable data and biospecimens: regulatory broad consent. Motivated by concerns regarding autonomy and trust in the research enterprise, regulators had initially proposed broad consent in a manner that would have rendered it the exclusive approach to secondary research with all biospecimens, regardless of identifiability. Based on public comments from both researchers and patients concerned that this approach would hinder important medical advances, however, regulators decided to (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  9.  14
    Opening Closed Doors: Promoting IRB Transparency.Holly Fernandez Lynch - 2018 - Journal of Law, Medicine and Ethics 46 (1):145-158.
    Institutional Review Boards have substantial power and authority over research with human subjects, and in turn, their decisions have substantial implications for those subjects, investigators, and the public at large. However, there is little transparency about IRB processes and decisions. This article provides the first comprehensive taxonomy of what transparency means for IRBs — answering the questions “to whom, about what, and by what mechanisms?” It also explains why the status quo of nontransparency is problematic, and presents arguments for greater (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  10.  17
    Patient‐Engaged Research: Choosing the “Right” Patients to Avoid Pitfalls.Emily A. Largent, Holly Fernandez Lynch & Matthew S. McCoy - 2018 - Hastings Center Report 48 (5):26-34.
    Direct download  
     
    Export citation  
     
    Bookmark   5 citations  
  11.  5
    The Right to Withdraw From Controlled Human Infection Studies: Justifications and Avoidance.Holly Fernandez Lynch - 2020 - Bioethics 34 (8):833-848.
    Direct download  
     
    Export citation  
     
    Bookmark   3 citations  
  12.  14
    No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.Jaime Webb, Lesha Shah & Holly Fernandez Lynch - 2020 - American Journal of Bioethics 20 (9):W1-W4.
    Volume 20, Issue 9, September 2020, Page W1-W4.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  13.  9
    Regulating Research with Biospecimens Under the Revised Common Rule.Holly Fernandez Lynch & Michelle N. Meyer - 2017 - Hastings Center Report 47 (3):3-4.
    Since 2011, the research community had waited with bated breath as regulators contemplated for the first time bringing secondary research with nonidentifiable biospecimens under the Common Rule and dramatically tightening the criteria for waiving consent to biospecimen research. After considerable pushback from both researchers and patients and amid rumors of intractable disagreement among Common Rule agencies, the Final Rule published on the last day of President Obama's administration left out these troubling changes, and there was a collective sigh of relief. (...)
    Direct download  
     
    Export citation  
     
    Bookmark   7 citations  
  14.  2
    Patient-Centered Outcomes Research: Stakeholder Perspectives and Ethical and Regulatory Oversight Issues.Emily A. Largent, Joel S. Weissman, Avni Gupta, Melissa Abraham, Ronen Rozenblum, Holly Fernandez Lynch & I. Glenn Cohen - 2018 - IRB: Ethics & Human Research 40 (1):7-17.
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark   4 citations  
  15.  15
    Confronting Biospecimen Exceptionalism in Proposed Revisions to the Common Rule.Holly Fernandez Lynch, Barbara E. Bierer & I. Glenn Cohen - 2016 - Hastings Center Report 46 (1):4-5.
    On September 8, 2015, the Department of Health and Human Services issued a Notice of Proposed Rule Making to revise the Federal Policy for the Protection of Human Subjects, widely known as the “Common Rule.” The NPRM proposes several changes to the current system, including a dramatic shift in the approach to secondary research using biospecimens and data. Under the current rules, it is relatively easy to use biospecimens and data for secondary research. This approach systematically facilitates secondary research with (...)
    Direct download  
     
    Export citation  
     
    Bookmark   5 citations  
  16.  11
    Filthy Lucre or Fitting Offer? Understanding Worries About Payments to Research Participants.Holly Fernandez Lynch, Ezekiel J. Emanuel & Emily A. Largent - 2019 - American Journal of Bioethics 19 (9):1-4.
    Volume 19, Issue 9, September 2019, Page 1-4.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  17.  7
    Prescription Requirements and Patient Autonomy: Considering an Over‐the‐Counter Default.Madison Kilbride, Steven Joffe & Holly Fernandez Lynch - 2020 - Hastings Center Report 50 (6):15-26.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  18.  7
    Evaluating the Quality of Research Ethics Review and Oversight: A Systematic Analysis of Quality Assessment Instruments.Holly Fernandez Lynch, Mohamed Abdirisak, Megan Bogia & Justin Clapp - 2020 - AJOB Empirical Bioethics 11 (4):208-222.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  19.  42
    Off-Label Prescription of COVID-19 Vaccines in Children: Clinical, Ethical, and Legal Issues.Govind Persad, Holly Fernandez Lynch & Patricia J. Zettler - 2021 - Pediatrics 2021:e2021054578.
    We argue that the universal recommendations against “off-label” pediatric use of approved COVID-19 issued by the FDA, CDC, and AAP are overbroad. Especially for higher-risk children, vaccination can be ethically justified even before FDA authorization or approval – and similar reasoning is relevant for even younger patients. Legal risks can also be managed, although the FDA, CDC, and Department of Health and Human Services (HHS) should move quickly to provide clarity.
    Direct download  
     
    Export citation  
     
    Bookmark  
  20.  11
    Incorporating Ethical Principles Into Clinical Research Protocols: A Tool for Protocol Writers and Ethics Committees.Rebecca H. Li, Mary C. Wacholtz, Mark Barnes, Liam Boggs, Susan Callery-D'Amico, Amy Davis, Alla Digilova, David Forster, Kate Heffernan, Maeve Luthin, Holly Fernandez Lynch, Lindsay McNair, Jennifer E. Miller, Jacquelyn Murphy, Luann Van Campen, Mark Wilenzick, Delia Wolf, Cris Woolston, Carmen Aldinger & Barbara E. Bierer - 2016 - Journal of Medical Ethics 42 (4):229-234.
    Direct download (10 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  21.  10
    A Proposal to Address NFL Club Doctors’ Conflicts of Interest and to Promote Player Trust.I. Glenn Cohen, Holly Fernandez Lynch & Christopher R. Deubert - 2016 - Hastings Center Report 46 (S2):2-24.
    How can we ensure that players in the National Football League receive excellent health care they can trust from providers who are as free from conflicts of interest as realistically possible? NFL players typically receive care from the club's own medical staff. Club doctors are clearly important stakeholders in player health. They diagnose and treat players for a variety of ailments, physical and mental, while making recommendations to the player concerning those ailments. At the same time, club doctors have obligations (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  22.  18
    On Scarcity and the Value of Clinical Trials.Luke Gelinas, Holly Fernandez Lynch, Barbara E. Bierer & I. Glenn Cohen - 2018 - American Journal of Bioethics 18 (4):71-73.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  23.  15
    Nonexceptionalism, Research Risks, and Social Media: Response to Open Peer Commentaries on “Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations”.Luke Gelinas, Robin Pierce, Sabune Winkler, Glenn Cohen, Holly Fernandez Lynch & Barbara E. Bierer - 2017 - American Journal of Bioethics 17 (5):1-3.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  24.  14
    Ethical Evasion or Happenstance and Hubris?Holly Fernandez Lynch - 2012 - Hastings Center Report 42 (2):30-38.
  25.  17
    The Rights and Wrongs of Intentional Exposure Research: Contextualising the Guatemala STD Inoculation Study.Holly Fernandez Lynch - 2012 - Journal of Medical Ethics 38 (8):513-515.
    In its recent review of the US Public Health Service Sexually Transmitted Disease Inoculation Study, conducted in Guatemala from 1946 to 1948, the Presidential Commission for the Study of Bioethical Issues identified a number of egregious ethical violations, but failed to adequately address issues associated with the intentional exposure research design in particular. As a result, a common public misconception that the study was wrong because researchers purposefully infected their subjects has been left standing. In fact, human subjects have been (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  26.  10
    Streamlining Review by Accepting Equivalence.Holly Fernandez Lynch & I. Glenn Cohen - 2014 - American Journal of Bioethics 14 (5):11-13.
  27.  3
    Allocation of Opportunities to Participate in Clinical Trials During the Covid‐19 Pandemic and Other Public Health Emergencies.Kayte Spector-Bagdady, Holly Fernandez Lynch, Barbara E. Bierer, Luke Gelinas, Sara Chandros Hull, David Magnus, Michelle N. Meyer, Richard R. Sharp, Jeremy Sugarman, Benjamin S. Wilfond, Ruqaiijah Yearby & Seema Mohapatra - 2022 - Wiley: Hastings Center Report 52 (1):51-58.
    Hastings Center Report, Volume 52, Issue 1, Page 51-58, January/February 2022.
    Direct download  
     
    Export citation  
     
    Bookmark  
  28.  25
    Mountains and Molehills When Using Social Media as a Research Support Tool.Holly Fernandez Lynch & Emily A. Largent - 2019 - American Journal of Bioethics 19 (6):64-66.
    Volume 19, Issue 6, June 2019, Page 64-66.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  29.  27
    A Functional Approach to Assessing Consent for Biospecimen Research.Holly Fernandez Lynch - 2017 - American Journal of Bioethics 17 (12):20-23.
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark  
  30. INTRODUCTION Health Law and Anti-Racism: Reckoning and Response.Michele Goodwin & Holly Fernandez Lynch - 2022 - Journal of Law, Medicine and Ethics 50 (1):10-14.
    Law and racism are intertwined, with legal tools bearing the potential to serve as instruments of oppression or equity. This Special Issue explores this dual nature of health law, with attention to policing in the context of mental health, schools, and substance use disorders; industry and the environment in the context of food advertising, tobacco regulation, worker safety, and environmental racism; health care and research in the context of infant mortality, bias in medical applications of AI, and diverse inclusion in (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  31. Allocation of Opportunities to Participate in Clinical Trials During the Covid‐19 Pandemic and Other Public Health Emergencies.Kayte Spector-Bagdady, Holly Fernandez Lynch, Barbara E. Bierer, Luke Gelinas, Sara Chandros Hull, David Magnus, Michelle N. Meyer, Richard R. Sharp, Jeremy Sugarman, Benjamin S. Wilfond, Ruqaiijah Yearby & Seema Mohapatra - 2022 - Wiley: Hastings Center Report 52 (1).
    Hastings Center Report, Volume 52, Issue 1, Page 51-58, January/February 2022.
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  32. Allocation of Opportunities to Participate in Clinical Trials During the Covid‐19 Pandemic and Other Public Health Emergencies.Kayte Spector-Bagdady, Holly Fernandez Lynch, Barbara E. Bierer, Luke Gelinas, Sara Chandros Hull, David Magnus, Michelle N. Meyer, Richard R. Sharp, Jeremy Sugarman, Benjamin S. Wilfond, Ruqaiijah Yearby & Seema Mohapatra - 2022 - Hastings Center Report 52 (1):51-58.
    Direct download  
     
    Export citation  
     
    Bookmark  
  33. Curbside Consults in Clinical Medicine: Empirical and Liability Challenges.Rachel L. Zacharias, Eric A. Feldman, Steven Joffe & Holly Fernandez Lynch - 2021 - Journal of Law, Medicine and Ethics 49 (4):599-610.
    In most U.S. jurisdictions, clinicians providing informal “curbside” consults are protected from medical malpractice liability due to the absence of a doctor-patient relationship. A recent Minnesota Supreme Court case, Warren v. Dinter, offers the opportunity to reassess whether the majority rule is truly serving the best interests of patients.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  34.  20
    Institutions as an Ethical Locus of Research Prioritisation.Luke Gelinas, Holly Fernandez Lynch, Barbara Bierer & I. Glenn Cohen - 2017 - Journal of Medical Ethics 43 (12):816-818.
    Ensuring that clinical trials, once launched, successfully complete and generate useful knowledge is an important and indeed ethically imperative goal, given the risks and burdens borne by research participants. Since there are insufficient willing research participants to power all the trials that are currently undertaken,1 addressing underenrolment will require prioritisation decisions that reduce the number of trials competing for participants. While there are multiple levels at which research priority-setting can and does take place, competition between trials often plays out in (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  35.  10
    Minimal or Reasonable? Considering the Ethical Threshold for Research Risks to Nonconsenting Bystanders and Implications for Nonconsenting Participants.Holly Fernandez Lynch - 2020 - Bioethics 34 (9):923-932.
    Direct download  
     
    Export citation  
     
    Bookmark  
  36.  16
    Mutual Obligations in Research and Withholding Payment From Deceptive Participants.Holly Fernandez Lynch, Luke Gelinas & Emily A. Largent - 2018 - American Journal of Bioethics 18 (4):85-87.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  37.  15
    The Legality of Biometric Screening of Professional Athletes.Jessica L. Roberts, I. Glenn Cohen, Christopher R. Deubert & Holly Fernandez Lynch - 2017 - American Journal of Bioethics 17 (1):65-67.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  38.  15
    A Response to Commentaries.I. Glenn Cohen, Holly Fernandez Lynch & Christopher R. Deubert - 2016 - Hastings Center Report 46 (S2):45-48.
    Our article “NFL Player Health Care: Addressing Club Doctors’ Conflicts of Interests and Promoting Player Trust” focused on an inherent structural conflict that faces club doctors in the National Football League. The conflict stems from club doctors’ dual role of providing medical care to players and providing strategic advice to clubs. We recommended assigning these roles to different individuals, with the medical staff members who are responsible for providing player care being chosen and subject to review and termination by a (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  39.  10
    Adding Insult to Injury: Reluctance to Engage in Clinical Research with At-Risk Groups Further Disenfranchises These Populations.Holly Fernandez Lynch & Liza Dawson - 2009 - American Journal of Bioethics 9 (11):62-64.
  40. Michael Hauskeller is an Associate Pro.Holly Fernandez Lynch - forthcoming - Hastings Center Report.
     
    Export citation  
     
    Bookmark  
  41.  4
    Physicians Often Enter Theprofessionofmedicinebe-Causetheywish Allydogood.Holly Fernandez Lynch - 2009 - In Vardit Ravitsky, Autumn Fiester & Arthur L. Caplan (eds.), The Penn Center Guide to Bioethics. Springer Publishing Company.
    Direct download  
     
    Export citation  
     
    Bookmark